Im Rahmen der externen Qualitätssicherung versuchen wir mit jedem möglichen Parameter an externen Qualitätssicherungs-Programmen teilzunehmen.
Die Zertifikate über die erfolgreiche Teilnahme sind unter einer fortlaufenden Nummer als PDF-Dokumente in der unten aufgeführten Tabelle hinterlegt. Durch "Anklicken" der Nummer können die ausgewählten Zertifikate aufgerufen werden.
|
|
| gültig bis einschl. |
RILI-BÄK-pflichtige Parameter | | | Apr | Mär | Feb | Jan | Dez | Nov | Okt | Sep | Aug | Jul | Jun | Mai |
---|
Stand 30.05.2022 | 2024 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 |
---|
C- Peptid | Plasma | 300 | | | | | | | | | | | | |
C3- Komplement | Serum | IG | | | | | | | | | | | | |
C4- Komplement | Serum | IG | | | | | | | | | | | | |
CA 12-5 | Serum | TM | | | | | | | | | | | | |
CA 15-3 | Serum | TM | | | | | | | | | | | | |
CA 19-9 | Serum | TM | | | | | | | | | | | | |
CA 72-4 | Serum | TM | | | | | | | | | | | | |
Calcitonin | Serum | TM | | | | | | | | | | | | |
Calcium | Serum | 100/KS | | | | | | | | | | | | |
Calcium i.U. | Urin | -- | | | | | | | | | | | | |
Calprotectin | Stuhl | 130/ FD | | | | | | | | | | | | |
Carbamazepin | Serum | AK | | | | | | | | | | | | |
Cardiolipin-AK IgG | Serum | AI | | | | | | | | | | | | |
Cardiolipin-AK IgM | Serum | AI | | | | | | | | | | | | |
CCP- AK | Serum | RF | | | | | | | | | | | | |
CDT (Carb. def. Transferrin) | Serum | 750/DT | | | | | | | | | | | | |
CEA | Serum | TM | | | | | | | | | | | | |
CFTR (gen.) | Blut | 778 | | | | | | | | | | | | |
Chlamydia Pneumon. IgA-AK | Serum | 314 | | | | | | | | | | | | |
Chlamydia Pneumon. IgG-AK | Serum | 314 | | | | | | | | | | | | |
Chlamydia pneumoniae- Genom | PCR | BakNAT1 | | | | | | | | | | | | |
Chlamydia Trachom. IgA-AK | Serum | 312 | | | | | | | | | | | | |
Chlamydia Trachom. IgG-AK | Serum | 312 | | | | | | | | | | | | |
Chlamydia trachomatis- Genom | PCR | 530 | | | | | | | | | | | | |
Chlorid | Serum | KS | | | | | | | | | | | | |
Cholesterin | Serum | LP | | | | | | | | | | | | |
Cholinesterase | Serum | 100/KS | | | | | | | | | | | | |
Coronaviren (RNA) qual. | PCR | 431 | | | | | | | | | | | | |
Coronavirus SARS-CoV-2 RNA (Covid19) | Abstrich | 340 | | | | | | | | | | | | |
Cortisol | Serum | HM | | | | | | | | | | | | |
Creatinin | Serum | 100/KS | | | | | | | | | | | | |
Creatinin i.U. | Urin | KU | | | | | | | | | | | | |
Creatinkinase (CK) | Serum | 100/KS | | | | | | | | | | | | |
CRP | Serum | IG | | | | | | | | | | | | |
Cyclosporin | Blut | CS | | | | | | | | | | | | |
CYP21B (gen.) | Blut | 773 | 1375 | | | | | | | | | | | |
CYP2C9 (gen.) | Blut | MG2 | | | | | | | | | | | | |
Cytomegalie Anti-CMV-IgG | Serum | CMVimm | | | | | | | | | | | | |
Cytomegalie Anti-CMV-IgG-Avidität | Serum | 351 | | | | | | | | | | | | |
Cytomegalie Anti-CMV-IgM | Serum | CMVimm | | | | | | | | | | | | |
|